Enumeration of not only EpCAM+CTCs but also EMT+CTCs, circulating macrophages and pairs/clusters of cells may be a viable option for characterization of tumor aggressiveness in human prostate cancer patients. The gene discussed is EPCAM; the disease is prostate carcinoma.